Skip to main content

and
  1. No Access

    Article

    Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children’s Research Hospital

    The intraventricular route of chemotherapy administration, via an Ommaya Reservoir (OmR) improves drug distribution in the central nervous system (CNS) compared to the more commonly used intrathecal administra...

    Alyssa Gaietto, John C Panetta, Jennifer L Pauley in Cancer Chemotherapy and Pharmacology (2024)

  2. No Access

    Article

    Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia

    Polyethylene glycol (PEG)-asparaginase (pegaspargase) is a key agent in chemotherapy for acute lymphoblastic leukemia (ALL), but recipients frequently experience allergic reactions. We hypothesized that by dec...

    Keito Hoshitsuki, Yinmei Zhou, April M. Miller, John K. Choi, Hope D. Swanson in Leukemia (2023)

  3. No Access

    Article

    Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma

    The Stanford V chemotherapy regimen has been used to treat Hodgkin lymphoma (HL) patients since 2002 with excellent cure rates; however, mechlorethamine is no longer available. Bendamustine, a drug structurall...

    Katelyn N. Purvis, Hope D. Swanson in Cancer Chemotherapy and Pharmacology (2023)